Browsing by Subject ganetespib

Showing results 1 to 1 of 1
Issue DateTitleAuthor(s)
1-Jan-2015A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)Ramalingam S.; Goss G.; Rosell R.; Schmid-Bindert G.; Bojan Zarić ; Andric Z.; Bondarenko I.; Komov D.; Ceric T.; Khuri F.; Samarzija M.; Felip E.; Ciuleanu T.; Hirsh V.; Wehler T.; Spicer J.; Salgia R.; Shapiro G.; Sheldon E.; Teofilovici F.; Vuković, V.; Fennell D.